NCT04405817 is a clinical trial of ECMO in Cardiogenic Shock, sponsored by Nanjing Medical University.

Who is sponsoring NCT04405817?

NCT04405817 is sponsored by Nanjing Medical University.

What drugs are being tested in NCT04405817?

Interventions in NCT04405817: ECMO.

What condition does NCT04405817 study?

NCT04405817 studies Cardiogenic Shock, Cardiac Arrest, Heart Failure, Acute Respiratory Failure, Acute Respiratory Distress Syndrome.

Is NCT04405817 still recruiting?

NCT04405817 is currently status unknown. Last updated 28 May 2020.

Last reviewed 2020-05-28 · How we verify

NCT04405817

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Outcome of Patients Treated With ECLS

Status unknown Last updated 28 May 2020

What this trial tests

trial testing ECMO in Cardiogenic Shock in 300 participants. Status unknown.

Timeline

1 January 2012

Primary endpoint
31 December 2025

31 December 2025

Quick facts

Lead sponsor	Nanjing Medical University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	300
Start date	1 January 2012
Primary completion	31 December 2025
Estimated completion	31 December 2025
Sites	1 location across China

Drugs / interventions tested

ECMO

Conditions studied

Cardiogenic Shock — all drugs for Cardiogenic Shock →
Cardiac Arrest — all drugs for Cardiac Arrest →
Heart Failure — all drugs for Heart Failure →
Acute Respiratory Failure — all drugs for Acute Respiratory Failure →

Sponsor

Nanjing Medical University

Who can join

Adults 1 to 100, any sex, with Cardiogenic Shock or Cardiac Arrest. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Extracorporeal life support (ECLS), also called extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective circulatory and (or) respiratory failure, with a growing number of critically ill patients benefit from it. The aim of this study is to investigate the outcome of patients treated With ECMO, and to evaluate the short-term and long-term outcomes of patients with ECLS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ECMO

Trials testing the same drug.

NCT05730881 — Comparison of Four Intensive Care Scores in Prediction of VA-ECMO Survival. · unknown
NCT05158816 — Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19 · completed
NCT04709432 — ECMO Treatment of Children in China in the Past 10 Years · recruiting
NCT03948048 — Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock · recruiting
NCT03607760 — Extracorporeal Membrane Oxygenation (ECMO) · completed

Other recruiting trials for Cardiogenic Shock

Currently open trials in the same condition.

NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
NCT07345559 — Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock · NA · recruiting
NCT07374289 — On Scene ECPR in Ostrava · NA · recruiting
NCT07402018 — Intra-aortic Balloon Counterpulsation (IABC) Compliance · recruiting
NCT07309029 — Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR · recruiting

Other Nanjing Medical University trials

Trials by the same sponsor.

NCT07382375 — AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection · NA · not yet recruiting
NCT07494474 — Risk Assessment of Pancreatic Islet Autoimmunity in Patients With AITD · not yet recruiting
NCT07482774 — Tumor Microenvironment Changes After Neoadjuvant Chemo-Immunotherapy in Esophageal Squamous Cell Carcinoma · not yet recruiting
NCT07348328 — Vitamin B Supplementation for Patients Undergoing Cardiovascular Surgery · NA · not yet recruiting
NCT07258394 — Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04405817 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nanjing Medical University
Last refreshed: 28 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04405817.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing